CAN

0.00%

55.0¢

CANN GROUP LIMITED

Market Cap $152.8M Add to my watchlist

ASX Cannabis showcase

Medicinal cannabis player Creso Pharma (CPH) is set to acquire Halucenex Life Sciences, a Canadian psychedelics treatment company.Creso has signed an agreement to buy the life sciences developer, which is geared towards researching and developing psychedelic...

Latest Threads

Tag

Subject

CAN

Creso Pharma (ASX:CPH) eyes medicinal psychedelics market

27/03/21

3.4K

27/03/21

Last post KelpieInvestor

3.4K

CAN

Mildura site is a busy place

11/04/21

2.5K

11/04/21

Last post Jafs

2.5K

CAN

Ann: Cann and Emyria investor webinar

09/04/21

3.1K

09/04/21

Last post jcurve

3.1K

CAN

Sell! Sell!

01/04/21

20K

01/04/21

Last post Marek78

20K

CAN

Ann: EMD: Emyria and Cann Group Investor Webinar

30/03/21

214

30/03/21

Last post

ASX News

214

CAN

Ann: Cann commences proceeding in Hong Kong to recover funds

29/03/21

1.3K

29/03/21

Last post Tsanga

1.3K

CAN

Ann: Cann and Emyria partner to register CBD product

29/03/21

1.5K

29/03/21

Last post kvsae

1.5K

CAN

Ann: EMD: Emyria and Cann Partner to Register CBD Product

29/03/21

258

29/03/21

Last post

ASX News

258

See All Discussions

Timeline

Cann and Emyria investor webinar
30 Mar 15:32	Share

EMD: Emyria and Cann Group Investor Webinar
30 Mar 15:24	Share

Cann commences proceeding in Hong Kong to recover funds
29 Mar 15:09	Share

EMD: Emyria and Cann Partner to Register CBD Product
29 Mar 09:22	Share

Cann and Emyria partner to register CBD product
29 Mar 09:22	Share

Notice under section 708A(5(e) of the Corporations Act
11 Mar 14:12	Share

Cann completes acquisition of Satipharm business
10 Mar 14:37	Share

Appendix 2A - Issue of shares for Satipharm acquisition
10 Mar 14:33	Share

Cann supplies medicinal cannabis for clinical trial
09 Mar 09:00	Share

Cann Group - Half yearly investor presentation
22 Feb 08:56	Share

Cann releases half-year results - 31 December 2020
22 Feb 08:55	Share

Half Yearly Report and Accounts
22 Feb 08:54	Share

HY21 Results - investor webinar
19 Feb 14:59	Share

Notice under s708A(5)(e) - issue of shares
19 Feb 08:49	Share

Appendix 2A - Issue of shares to CSIRO
19 Feb 08:45	Share

Appendix 2A - Exercise of options
19 Feb 08:44	Share

Proposed issue of Securities - CAN
18 Feb 14:07	Share

Replacement Appendix 2A
17 Feb 10:07	Share

Notice under s.708A(5)(e)
17 Feb 10:07	Share

Federal Court orders granted
17 Feb 10:04	Share

Trading Halt
16 Feb 08:59	Share

Cann investor update
15 Feb 08:24	Share

Proposed issue of Securities - CAN
15 Feb 08:23	Share

Cann executes agreement to acquire Satipharm business
15 Feb 08:23	Share

Cann provides revenue update
15 Feb 08:16	Share

Cyber security incident
08 Feb 09:30	Share

Correction of trading halt request
05 Feb 14:08	Share

Trading Halt
05 Feb 10:45	Share

Pause in Trading
05 Feb 10:22	Share

Appendix 4C - quarterly
28 Jan 11:26	Share

View More

(20min delay) Trade with IG
Last 55.0¢		Change 0.000(0.00%)		Mkt cap ! $152.8M

Open	High	Low	Value	Volume
55.0¢	56.0¢	54.0¢	$193.3K	351.3K

Buyers (Bids)

No.	Vol.	Price($)
1	9720	55.0¢

Sellers (Offers)

Price($)	Vol.	No.
55.5¢	83671	4

View Market Depth

No.	Vol.	Price($)
1	8500	0.545
4	29196	0.540
6	61232	0.535
15	79301	0.530
7	66957	0.525

Price($)	Vol.	No.
0.555	21833	3
0.560	50208	6
0.565	51500	2
0.570	64961	2
0.575	15958	2

Last trade - 16.10pm 09/04/2021 (20 minute delay)

(live)
Last 55.5¢		Change 0.000 ( 0.91 %)
Open	High	Low	Volume
54.0¢	56.0¢	54.0¢	105426
Last updated 15.56pm 09/04/2021 (live) ?

CAN (ASX) Chart